SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-210791
Filing Date
2023-08-11
Accepted
2023-08-11 16:26:56
Documents
1
Effectiveness Date
2023-08-11

Document Format Files

Seq Description Document Type Size
1 S-8 POS d543450ds8pos.htm S-8 POS 22516
  Complete submission text file 0001193125-23-210791.txt   23532
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-263536 | Film No.: 231164507
SIC: 2834 Pharmaceutical Preparations